Aptose Biosciences Inc (NASDAQ: APTO) rose 18.9 percent to $3.78 in pre-market trading after the company reported an exclusive license agreement with OHM Oncology for dual BET/kinase targeting program.
Medifast Inc (NYSE: MED)...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.